Operating Income (Loss) in USD of Nascent Biotech Inc. from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Nascent Biotech Inc. quarterly/annual Operating Income (Loss) history and change rate from Q4 2013 to Q2 2024.
  • Nascent Biotech Inc. Operating Income (Loss) for the quarter ending 30 Jun 2024 was -$376K, a 26.6% increase year-over-year.
  • Nascent Biotech Inc. Operating Income (Loss) for the twelve months ending 30 Jun 2024 was -$2.09M, a 2.22% decline year-over-year.
  • Nascent Biotech Inc. annual Operating Income (Loss) for 2023 was -$2.23M, a 3.44% decline from 2022.
  • Nascent Biotech Inc. annual Operating Income (Loss) for 2022 was -$2.16M, a 372% decline from 2021.
  • Nascent Biotech Inc. annual Operating Income (Loss) for 2021 was -$457K, a 67.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Nascent Biotech Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$2.09M -$376K +$136K +26.6% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 -$2.23M -$516K +$23.8K +4.41% 01 Jan 2024 31 Mar 2024 10-K 01 Jul 2024
Q4 2023 -$2.25M -$364K +$111K +23.3% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2024
Q3 2023 -$2.36M -$837K -$316K -60.7% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 -$2.05M -$512K +$108K +17.4% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$2.16M -$540K -$125K -30.1% 01 Jan 2023 31 Mar 2023 10-K 01 Jul 2024
Q4 2022 -$2.03M -$475K -$1.11M -175% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024
Q3 2022 -$925K -$521K -$291K -126% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$634K -$620K -$177K -39.9% 01 Apr 2022 30 Jun 2022 10-Q 18 Aug 2023
Q1 2022 -$457K -$415K -$682K -255% 01 Jan 2022 31 Mar 2022 10-K/A 03 Jul 2023
Q4 2021 $225K $631K +$1.19M 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023
Q3 2021 -$961K -$230K +$331K +59% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$1.29M -$443K +$109K +19.7% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 -$1.4M $267K +$2.74M 01 Jan 2021 31 Mar 2021 10-K 15 Jun 2022
Q4 2020 -$4.15M -$555K -$187K -50.7% 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022
Q3 2020 -$3.96M -$561K -$233K -71.3% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 -$3.72M -$551K -$278K -101% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$3.45M -$2.48M -$2.14M -640% 01 Jan 2020 31 Mar 2020 10-K 08 Jul 2021
Q4 2019 -$1.3M -$368K -$112K -43.5% 01 Oct 2019 31 Dec 2019 10-Q 09 Feb 2021
Q3 2019 -$1.19M -$328K +$10.5K +3.1% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 -$1.2M -$274K +$166K +37.7% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020
Q1 2019 -$1.37M -$335K +$467K +58.2% 01 Jan 2019 31 Mar 2019 10-K 22 Jun 2020
Q4 2018 -$1.84M -$257K +$307K +54.5% 01 Oct 2018 31 Dec 2018 10-Q 11 Feb 2020
Q3 2018 -$2.14M -$338K +$220K +39.4% 01 Jul 2018 30 Sep 2018 10-Q 18 Nov 2019
Q2 2018 -$2.36M -$440K -$141K -47.3% 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2019
Q1 2018 -$2.22M -$801K -$337K -72.6% 01 Jan 2018 31 Mar 2018 10-K 12 Jul 2019
Q4 2017 -$1.88M -$564K +$6.08K +1.07% 01 Oct 2017 31 Dec 2017 10-Q 13 Feb 2019
Q3 2017 -$1.89M -$558K -$2.29M -132% 01 Jul 2017 30 Sep 2017 10-Q 05 Nov 2018
Q2 2017 $399K -$299K -$1.03M -141% 01 Apr 2017 30 Jun 2017 10-Q 06 Aug 2018
Q1 2017 $1.43M -$464K +$133K +22.2% 01 Jan 2017 31 Mar 2017 10-K 29 Jun 2018
Q4 2016 $1.29M -$570K -$304K -114% 01 Oct 2016 31 Dec 2016 10-Q 31 Jan 2018
Q3 2016 $1.6M $1.73M +$3.98M 01 Jul 2016 30 Sep 2016 10-Q 03 Nov 2017
Q2 2016 -$2.38M $730K +$1.49M 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017
Q1 2016 -$3.87M -$597K +$317K +34.7% 01 Jan 2016 31 Mar 2016 10-K 29 Jun 2017
Q4 2015 -$4.19M -$266K +$389K +59.4% 01 Oct 2015 31 Dec 2015 10-Q 09 Feb 2017
Q3 2015 -$4.58M -$2.25M -$1.92M -596% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 -$2.65M -$760K -$529K -228% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016
Q1 2015 -$2.12M -$914K 01 Jan 2015 31 Mar 2015 10-K 14 Jul 2016
Q4 2014 -$655K -$589K -900% 01 Oct 2014 31 Dec 2014 10-Q 19 Feb 2016
Q3 2014 -$323K 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015
Q2 2014 -$232K 01 Apr 2014 30 Jun 2014 10-Q 30 Jul 2015
Q4 2013 -$65.4K 01 Oct 2013 31 Dec 2013 10-Q 13 Feb 2015

Nascent Biotech Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2.23M -$74.1K -3.44% 01 Apr 2023 31 Mar 2024 10-K 01 Jul 2024
2022 -$2.16M -$1.7M -372% 01 Apr 2022 31 Mar 2023 10-K 01 Jul 2024
2021 -$457K +$943K +67.4% 01 Apr 2021 31 Mar 2022 10-K/A 03 Jul 2023
2020 -$1.4M +$2.05M +59.4% 01 Apr 2020 31 Mar 2021 10-K 15 Jun 2022
2019 -$3.45M -$2.08M -152% 01 Apr 2019 31 Mar 2020 10-K 08 Jul 2021
2018 -$1.37M +$853K +38.4% 01 Apr 2018 31 Mar 2019 10-K 22 Jun 2020
2017 -$2.22M -$3.65M -256% 01 Apr 2017 31 Mar 2018 10-K 12 Jul 2019
2016 $1.43M +$5.3M 01 Apr 2016 31 Mar 2017 10-K 29 Jun 2018
2015 -$3.87M -$1.75M -82.3% 01 Apr 2015 31 Mar 2016 10-K 29 Jun 2017
2014 -$2.12M -$1.55M -272% 01 Apr 2014 31 Mar 2015 10-K 14 Jul 2016
2013 -$571K 01 Apr 2013 31 Mar 2014 10-K 02 Jul 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.